Humalog is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Insulin Lispro.
| Product ID | 70518-1388_75143195-5989-619d-e053-2a91aa0a5580 | 
| NDC | 70518-1388 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Humalog | 
| Generic Name | Insulin Lispro | 
| Dosage Form | Injection, Solution | 
| Route of Administration | INTRAVENOUS; SUBCUTANEOUS | 
| Marketing Start Date | 2018-08-27 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA020563 | 
| Labeler Name | REMEDYREPACK INC. | 
| Substance Name | INSULIN LISPRO | 
| Active Ingredient Strength | 100 [iU]/mL | 
| Pharm Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2019-12-31 | 
| Marketing Start Date | 2018-08-27 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA020563 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2018-08-27 | 
| Inactivation Date | 2020-01-31 | 
| Ingredient | Strength | 
|---|---|
| INSULIN LISPRO | 100 [iU]/mL | 
| SPL SET ID: | 7ea5ac79-79a7-442c-9c34-3b6477367928 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| PHarm Class EPC | |
| NUI Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0002-7510 | Humalog | Insulin lispro | 
| 0002-7511 | Humalog | Insulin lispro | 
| 0002-7512 | Humalog | Insulin lispro | 
| 0002-7516 | Humalog | Insulin lispro | 
| 0002-7712 | Humalog | Insulin lispro | 
| 0002-7714 | Humalog | Insulin lispro | 
| 70518-1388 | Humalog | Humalog | 
| 50090-1375 | Humalog | Humalog | 
| 55045-3602 | Humalog | Humalog | 
| 50090-4488 | Humalog | Humalog | 
| 70518-2264 | Humalog | Humalog | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() HUMALOG  74314093  1963572 Live/Registered  | 
        Eli Lilly and Company  1992-09-15  |